| Name | Gunsynd |
|---|---|
| Epic | GUN |
| Isin | GB00BMD6PM55 |
| Industry | Pharmaceuticals & Biotechnology |
| Latest share price | 0.12p | Net gearing | n/a |
|---|---|---|---|
| Market capitalisation | £1.15 | Debt ratio | n/a |
| Shares in issue | 571.80 | Debt-to-equity ratio | n/a |
| P/E ratio | n/a | Assets / equity ratio | n/a |
| Total dividends per share | n/a | Price to book value | n/a |
| Dividend yield | n/a | ROCE | -79.67 |
| Dividend cover | n/a | EPS growth | n/a |
| Earning per share | -0.38 | 52-week high / low | 0.12p / 0.33p |
| Type | Ex-date | Pay-date | Net-dividend |
|---|---|---|---|
| No dividends declared | |||
| Company name | Gunsynd |
|---|---|
| Address | 78 Pall Mall, St. James's, London, United Kingdom, SW1Y 5ES |
| Telephone | |
| Website | http://gunsynd.com/ |
| Director | Position |
|---|---|
| Mr Donald Strang | Executive Director |
| Mr Hamish Harris | Executive Chairman |
| Mr Peter James Ruse | Independent Non-Executive Director |
| Assets £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Reporting date | 31/07/23 | 31/07/22 | 31/07/21 |
| Intangible asssets and goodwill | n/a | n/a | n/a |
| Investments and other non-current assets | 1.89 | 2.94 | 5.12 |
| Total non-current assets | 1.89 | 2.94 | 5.12 |
| Inventory / work in progress | n/a | n/a | n/a |
| Trade and other receivables | 0.19 | 0.16 | 0.17 |
| Cash and equivalents | 0.16 | 0.82 | 1.07 |
| Other current assets and asset held for resale | n/a | n/a | n/a |
| Total of all assets | 2.25 | 3.93 | 6.37 |
| Liabilities £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Short term liabilities | 0.1 | 0.08 | 0.07 |
| Long term liabilities | n/a | n/a | n/a |
| Other liabilites / pension etc | n/a | n/a | n/a |
| Total of all liabilities | 0.1 | 0.08 | 0.07 |
| Net assets £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Net assets | 2.15 | 3.85 | 6.3 |
| Equity £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Share capital | 2.68 | 2.68 | 0.38 |
| Minority interests | n/a | n/a | n/a |
| Retained earnings | -13.99 | -12.3 | -9.97 |
| Share premium account | 13.46 | 13.46 | 13.46 |
| Total equity | 2.15 | 3.85 | 6.3 |
| Income £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Turnover | n/a | n/a | n/a |
| Operating profit | -1.71 | -2.46 | 1.93 |
| Pre-tax profit | -1.71 | -2.43 | 2.01 |